98%
921
2 minutes
20
Intracellular Methicillin-Resistant Staphylococcus aureus (MRSA) remains a major factor of refractory and recurrent infections, which cannot be well addressed by antibiotic therapy. Here, we design a cellular infectious microenvironment-activatable polymeric nano-system to mediate targeted intracellular drug delivery for macrophage reprogramming and intracellular MRSA eradication. The polymeric nano-system is composed of a ferrocene-decorated polymeric nanovesicle formulated from poly(ferrocenemethyl methacrylate)-block-poly(2-methacryloyloxyethyl phosphorylcholine) (PFMMA-b-PMPC) copolymer with co-encapsulation of clofazimine (CFZ) and interferon-γ (IFN-γ). The cellular-targeting PMPC motifs render specific internalization by macrophages and allow efficient intracellular accumulation. Following the internalization, the ferrocene-derived polymer backbone sequentially undergoes hydrophobic-to-hydrophilic transition, charge reversal and Fe release in response to intracellular hydrogen peroxide over-produced upon infection, eventually triggering endosomal escape and on-site cytosolic drug delivery. The released IFN-γ reverses the immunosuppressive status of infected macrophages by reprogramming anti-inflammatory M2 to pro-inflammatory M1 phenotype. Meanwhile, intracellular Fe-mediated Fenton reaction together with antibiotic CFZ contributes to increased intracellular hydroxyl radical (•OH) generation. Ultimately, the nano-system achieves robust potency in ablating intracellular MRSA and antibiotic-tolerant persisters by synchronous immune modulation and efficient •OH killing, providing an innovative train of thought for intracellular MRSA control.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.jconrel.2022.12.014 | DOI Listing |
mBio
September 2025
The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Torrance, California, USA.
Unlabelled: Methicillin-resistant (MRSA) is a leading cause of endovascular infections, where interactions with endothelial cells play a critical role in pathogenesis. Gp05, a prophage-encoded protein, has previously been implicated in promoting antibiotic persistence by modulating MRSA cellular physiology and evading neutrophil-mediated killing. In this study, we investigated the role of Gp05 in MRSA-endothelial cell interactions, focusing on its impact on bacterial adhesion, invasion, cytotoxicity, and the host inflammatory response.
View Article and Find Full Text PDFBiomed Res Int
September 2025
Department of Pharmacy, The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei, China.
Vancomycin is the first-line treatment for infection, and high plasma concentration can cause nephrotoxicity. The aim of the study was to determine the correlation between intracellular vancomycin concentration and HK-2 cytotoxicity and explore omeprazole's protective effect. The activity of HK-2 cells was detected, HPLC method was established and verified, and the vancomycin concentrations in the intracellular and extracellular fluids of HK-2 cells were determined.
View Article and Find Full Text PDFMicrobiol Spectr
September 2025
Microbiome-X, School of Public Health, Cheeloo College of Medicine, Shandong University, Jinan, China.
Novel antimicrobial agents are urgently needed to combat the antibiotic-resistance crisis, particularly in the face of multidrug-resistant (MDR) pathogens like carbapenem-resistant (CRAB) and methicillin-resistant (MRSA). In this study, we present an approach that combines generative large language model with sequence alignment to identify promising antimicrobial peptides. With this strategy, we rapidly identified five novel encrypted peptides based on a generated template, demonstrating significant antimicrobial activity against a broad spectrum of clinical MDR pathogens.
View Article and Find Full Text PDFEur J Med Chem
December 2025
School of Life Science and Technology, Shandong Second Medical University, Shandong, China. Electronic address:
With rising antimicrobial resistance and continuous failure of conventional therapies, innovative drug development against methicillin-resistant Staphylococcus aureus (MRSA) is crucial for effective clinical treatment. Here, new dimethyl quaternary ammonium salt 5b derived from harmane were designed, exhibiting potent anti-MRSA activities including clinical strains (MIC = 0.25-0.
View Article and Find Full Text PDFInt J Mol Sci
August 2025
School of Pharmacy, Walailak University, Nakhon Si Thammarat 80161, Thailand.
Bacterial infection is a cause of life-threatening diseases. The emergence of antimicrobial-resistant bacteria exacerbates this situation, highlighting the need for the discovery of new antimicrobial agents. Our previous study identified a novel antimicrobial peptide, BrSPR20-P1 (P1), which showed potential activity against MRSA.
View Article and Find Full Text PDF